Nonhematologic toxicity according to the WHO classification19after ASCT and IFN-α maintenance
WHO toxicity and grade . | IFN, % . | ASCT, % . |
|---|---|---|
| No. | 122 | 105 |
| Mucositis | ||
| 1, 2 | 15.0 | 36.2 |
| 3, 4 | 0.0 | 53.3 |
| Infections | ||
| 1, 2 | 30.0 | 62.5 |
| 3, 4 | 1.7 | 23.1 |
| Nausea/vomiting | ||
| 1, 2 | 35.5 | 52.4 |
| 3, 4 | 1.7 | 32.4 |
| Diarrhea | ||
| 1, 2 | 8.3 | 48.1 |
| 3, 4 | 1.7 | 13.5 |
| Pulmonary | ||
| 1, 2 | 10.4 | 22.1 |
| 3, 4 | 0.9 | 4.8 |
| Liver | ||
| 1, 2 | 20.6 | 40.4 |
| 3, 4 | 0.9 | 3.8 |
| Renal | ||
| 1, 2 | 0.9 | 9.6 |
| 3, 4 | 0.0 | 1.0 |
| Muscle/bone pain | ||
| 1, 2 | 42.2 | 22.1 |
| 3, 4 | 11.0 | 2.1 |
| Depression | ||
| 1, 2 | 19.6 | 8.7 |
| 3, 4 | 4.9 | 1.1 |
WHO toxicity and grade . | IFN, % . | ASCT, % . |
|---|---|---|
| No. | 122 | 105 |
| Mucositis | ||
| 1, 2 | 15.0 | 36.2 |
| 3, 4 | 0.0 | 53.3 |
| Infections | ||
| 1, 2 | 30.0 | 62.5 |
| 3, 4 | 1.7 | 23.1 |
| Nausea/vomiting | ||
| 1, 2 | 35.5 | 52.4 |
| 3, 4 | 1.7 | 32.4 |
| Diarrhea | ||
| 1, 2 | 8.3 | 48.1 |
| 3, 4 | 1.7 | 13.5 |
| Pulmonary | ||
| 1, 2 | 10.4 | 22.1 |
| 3, 4 | 0.9 | 4.8 |
| Liver | ||
| 1, 2 | 20.6 | 40.4 |
| 3, 4 | 0.9 | 3.8 |
| Renal | ||
| 1, 2 | 0.9 | 9.6 |
| 3, 4 | 0.0 | 1.0 |
| Muscle/bone pain | ||
| 1, 2 | 42.2 | 22.1 |
| 3, 4 | 11.0 | 2.1 |
| Depression | ||
| 1, 2 | 19.6 | 8.7 |
| 3, 4 | 4.9 | 1.1 |